RecruitingNot ApplicableNCT04899544

Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism

Randomized Controlled Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism

Sponsor

Stanford University

Enrollment

120 participants

Start Date

Oct 18, 2022

Study Type

INTERVENTIONAL

Conditions

Autism Autism Spectrum Disorder ASD

Summary

The aim of this clinical trial is to compare the efficacy of a 16-week center-based Pivotal Response Treatment (PRT-C) versus home-based Pivotal Response Treatment (PRT-H) in targeting social communication deficits in young children with autism spectrum disorder (ASD) with significant language delay. The two groups will also be compared to a control group that consists of children who are receiving treatment as usual (TAU).

Eligibility

Min Age: 2 YearsMax Age: 5 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Center-Based Pivotal Response Treatment (PRT) Intervention (PRT-C) and a behavioral approach called Home-Based Pivotal Response Treatment (PRT Intervention (PRT-H) for people with asd, autism, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 2 Years to 5 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.